Healthcare Global Enterprises Ltd.
Snapshot View

291.00 +4.90 ▲1.7%

03 October 2022, 12:51:59 PM
Volume: 121,856

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.hcgoncology.com
Market Cap 4,068.11 Cr.
Enterprise Value(EV) 4,199.66 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.99 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 58.66 Trailing Twelve Months Ending 2022-06
Industry PE 49.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 62.27 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.70 Calculated using Price: 292.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 13.91 Cr. 139,080,762 Shares
FaceValue 10
Company Profile
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.71%
1 Week
+7.62%
1 Month
+8.18%
3 Month
+4.94%
6 Month
+5.66%
1 Year
+18.58%
2 Year
+141.90%
5 Year
+4.43%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -15.10 1.75 0.64 5.38 4.02 -4.18 -26.77 -43.32 5.16
Return on Capital Employed (%) -0.73 6.41 5.60 7.22 7.75 4.50 2.75 -9.66 15.17
Return on Assets (%) -5.91 0.64 0.25 2.06 1.39 -1.31 -5.87 -10.46 1.85

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 292 263 279 426 433 515 477 381 697 870
Non Curr. Liab. 256 257 279 306 354 483 557 1,232 822 860
Curr. Liab. 156 149 187 263 366 359 547 576 465 470
Minority Int. 17 18 25 33 57 64 46 39 17 13
Equity & Liab. 721 688 770 1,027 1,210 1,421 1,627 2,227 2,001 2,214
Non Curr. Assets 557 578 648 800 966 1,200 1,354 1,923 1,566 1,711
Curr. Assets 164 109 122 227 244 220 273 304 435 502
Misc. Exp. not W/O
Total Assets 721 688 770 1,027 1,210 1,421 1,627 2,227 2,001 2,214

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 450 519 584 700 829 976 1,092 1,009 1,395 1,483
Other Income 5 5 4 10 19 10 10 21 16 12
Total Income 455 524 588 710 848 986 1,103 1,030 1,410 1,495
Total Expenditure -413 -443 -499 -595 -716 -853 -923 -887 -1,160 -1,224
PBIDT 42 81 89 115 132 133 179 144 251 271
Interest -32 -34 -38 -23 -42 -70 -138 -119 -98 -96
Depreciation -36 -39 -44 -57 -71 -85 -148 -159 -158 -160
Taxation -5 2 2 -12 -10 3 -6 8 -49 -53
Exceptional Items -10 -5 -6 11 -93 95 95
PAT -42 5 2 23 18 -20 -113 -221 39 56
Minority Interest -2 -4 -4 -1 4 6 19 28 15 15
Share Associate -1 -11 -12 -2
Other Related Items
Consolidated Net Profit -44 1 -1 22 21 -25 -107 -193 54 69
Adjusted EPS -6 0 0 3 2 -3 -12 -15 4 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 29 50 60 73 91 98 99 130 121 220
Cash Fr. Inv. -100 -58 -80 -204 -210 -282 -238 -101 -171 125
Cash Fr. Finan. 66 23 22 216 89 161 84 -58 112 -155
Net Change -6 15 2 85 -29 -23 -56 -30 62 190
Cash & Cash Eqvt 11 25 25 80 51 27 -29 -59 3 193

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 23.90 66.91 66.87 70.71 68.41 68.40 71.44 71.43 71.42
Public 76.10 33.09 33.13 29.29 31.59 31.60 28.56 28.57 28.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 3.36 3.47 3.47 3.00 3.00 3.00

Announcements View Details >>

Fri, 30 Sep 2022
Annual General Meeting
Healthcare Global Enterprises Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 29-Sep-2022
Fri, 30 Sep 2022
Annual General Meeting
Healthcare Global Enterprises Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 29-Sep-2022
Wed, 28 Sep 2022
Investor Presentation
Healthcare Global Enterprises Limited has informed the Exchange about Investor Presentation

Technical Scans View Details >>

Fri, 30 Sep 2022
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 2 Years High Increase 2 Years
CCI Overbought Zone CCI Overbought Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 961.75 +1.4%
Divi's Laboratories Ltd. 97,811.90 3,797.00 +2.5%
Cipla Ltd. 89,996.82 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. 52,506.43 1,590.85 +2.0%
Abbott India Ltd. 40,438.70 18,900.00 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-06 36.17 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-06 50.01 18,900.00 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-06 4.19 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-06 13.56 18,900.00 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-03 0.00 18,900.00 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-03 29.95 18,900.00 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-03 29.95 18,900.00 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,900.00 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 961.75 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,797.00 +2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,144.50 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,408.85 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,441.35 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,590.85 +2.0%
Abbott India Ltd. Standalone 2022-03 798.70 18,900.00 -1.2%

FAQ's On Healthcare Global Enterprises Ltd.

What is HealthcareGlobal share price?

Can I buy HealthcareGlobal shares now?

What is the Market Cap of HealthcareGlobal?

What are the key metrics to analyse HealthcareGlobal?

What is the 52 Week High and Low of HealthcareGlobal?

What is the trend of HealthcareGlobal share price?